About William Ragatz
William Ragatz is a president and CEO, director at Sentrimed.
William Ragatz first appears on SEC filings in 2024.
Experience
This experience comes from William Ragatz's profile and from SEC filings. For roles taken from filings, the years are when the filings name William Ragatz in the role, so the role may have started earlier or lasted longer.
Sentrimed, Inc. Current
President and CEO, director
2022 – Present · Mullica Hill, NJ
Develops oral cancer treatments for people with head and neck cancer.
VB
Viela Bio
Senior Vice President, Head of Commercial
2019 – 2021
AS
AstraZeneca
Anifrolumab Director, Global Product and Portfolio Strategy
2017 – 2019
BI
Boehringer Ingelheim
Director Gilotrif Marketing
2002 – 2017
ME
Merck
Senior Product Manager - Singulair
1996 – 2001
Key Colleagues at Startups
The people William Ragatz works with at each company, as listed on that company's latest Form D.
Sentrimed, Inc. · Form D, May 13, 2026
AR
Arye Rosen
Vice President
JG
Jack Goldberg
Chief Medical Officer and director
MY
Mari Yin
Treasurer and director
GG
Gary Goldberg
Founder and Chief Science Officer
CL
Christopher Leonard
Secretary
BG
Bradley Galer
Director
TD
Tabbetha Dobbins
Director